trending Market Intelligence /marketintelligence/en/news-insights/trending/fxulzcoqkph0mxomnmiu7w2 content esgSubNav
In This List

Oramed Pharmaceuticals closes $18.1M common stock, warrants offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Oramed Pharmaceuticals closes $18.1M common stock, warrants offering

Oramed Pharmaceuticals Inc. said July 6 that it closed its registered direct offering with certain healthcare-focused institutional investors to raise about $18.1 million in gross proceeds.

The Israeli company offered 2,892,000 common shares and warrants to buy up to 2,892,000 common stock at a combined price of $6.25 per share and related warrant. The warrants will be exercisable six months after being issued at $7.25 per share.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.